$75.02
0.19% today
NYSE, Nov 04, 09:13 pm CET
ISIN
US3795772082
Symbol
GMED

Globus Medical, Inc. Class A Target price 2024 - Analyst rating & recommendation

Globus Medical, Inc. Class A Classifications & Recommendation:

Buy
67%
Hold
33%

Globus Medical, Inc. Class A Price Target

Target Price $81.58
Price $74.88
Potential
Number of Estimates 12
12 Analysts have issued a price target Globus Medical, Inc. Class A 2025 . The average Globus Medical, Inc. Class A target price is $81.58. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 15 analysts: 10 Analysts recommend Globus Medical, Inc. Class A to buy, 5 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Globus Medical, Inc. Class A stock has an average upside potential 2025 of . Most analysts recommend the Globus Medical, Inc. Class A stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 1.57 2.48
53.35% 58.36%
EBITDA Margin 22.10% 29.41%
25.81% 33.10%
Net Margin 9.23% 4.93%
62.28% 46.61%

13 Analysts have issued a sales forecast Globus Medical, Inc. Class A 2024 . The average Globus Medical, Inc. Class A sales estimate is

$2.5b
Unlock
. This is
11.06% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.5b 11.35%
Unlock
, the lowest is
$2.5b 10.89%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $1.6b 53.35%
2024
$2.5b 58.36%
Unlock
2025
$2.7b 6.93%
Unlock
2026
$2.8b 6.79%
Unlock
2027
$3.0b 7.37%
Unlock
2028
$3.3b 8.77%
Unlock

11 Analysts have issued an Globus Medical, Inc. Class A EBITDA forecast 2024. The average Globus Medical, Inc. Class A EBITDA estimate is

$730m
Unlock
. This is
78.77% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$769m 88.15%
Unlock
, the lowest is
$696m 70.35%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $347m 13.76%
2024
$730m 110.74%
Unlock
2025
$848m 16.08%
Unlock
2026
$949m 11.91%
Unlock
2027
$1.1b 16.31%
Unlock
2028
$1.2b 9.10%
Unlock

EBITDA Margin

2023 22.10% 25.81%
2024
29.41% 33.10%
Unlock
2025
31.92% 8.53%
Unlock
2026
33.46% 4.82%
Unlock
2027
36.24% 8.31%
Unlock
2028
36.35% 0.30%
Unlock

7 Globus Medical, Inc. Class A Analysts have issued a net profit forecast 2024. The average Globus Medical, Inc. Class A net profit estimate is

$122m
Unlock
. This is
201.42% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$207m 410.00%
Unlock
, the lowest is
$28.4m 29.99%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $145m 42.16%
2024
$122m 15.49%
Unlock
2025
$345m 181.68%
Unlock
2026
$392m 13.72%
Unlock
2027
$546m 39.13%
Unlock

Net Margin

2023 9.23% 62.28%
2024
4.93% 46.61%
Unlock
2025
12.98% 163.29%
Unlock
2026
13.83% 6.55%
Unlock
2027
17.91% 29.50%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 1.07 0.90
42.16% 15.89%
P/E 82.81
EV/Sales 4.10

7 Analysts have issued a Globus Medical, Inc. Class A forecast for earnings per share. The average Globus Medical, Inc. Class A <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.90
Unlock
. This is
200.00% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$1.53 410.00%
Unlock
, the lowest is
$0.21 30.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $1.07 42.16%
2024
$0.90 15.89%
Unlock
2025
$2.55 183.33%
Unlock
2026
$2.90 13.73%
Unlock
2027
$4.03 38.97%
Unlock

P/E ratio

Current 252.89 1,010.63%
2024
82.81 67.25%
Unlock
2025
29.40 64.50%
Unlock
2026
25.85 12.07%
Unlock
2027
18.58 28.12%
Unlock

Based on analysts' sales estimates for 2024, the Globus Medical, Inc. Class A stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.55 13.50%
2024
4.10 9.95%
Unlock
2025
3.83 6.48%
Unlock
2026
3.59 6.36%
Unlock
2027
3.34 6.86%
Unlock
2028
3.07 8.06%
Unlock

P/S ratio

Current 4.53 22.08%
2024
4.08 9.96%
Unlock
2025
3.82 6.48%
Unlock
2026
3.58 6.35%
Unlock
2027
3.33 6.86%
Unlock
2028
3.06 8.06%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today